MedPath

Evaluation of outcomes of radiotherapy in metastatic spinal cord compression in lung cancer

Completed
Conditions
metastatic spinal cord compression in lung cancer
Registration Number
CTRI/2016/06/006981
Lead Sponsor
Tata Memorial Centre
Brief Summary

a prospective observational study to evaluatethe outcomes of radiotherapy in patient of lung cancer with metastatic spinalcord compression in terms of  painrelief, improvement in motor function, sphincter control and overall survivalat 6 months

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria
  • •Age 18 years and above •NSCLC/SCLC •Presence of solitary or multiple tumour deposits/soft tissue mass/metastatic disruption of the bony cortex around the spinal cord that are extrinsically compressing the thecal sac as diagnosed on MRI or CT or evidence of clinical myeloradiculopathy with or without osteolysis evident on X-Ray and or Bone Scan in patients with progressive neoplastic disease.
  • •Informed consent (although have requested for waiver of consent from IEC).
Exclusion Criteria

•Surgical intervention for treatment of MSCC •Previous irradiation in the affected region of the spine.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective of this study is to evaluate the various radiotherapy regimen 2 weeks, 1 month and 6 months after completion of RT, with respect to :NIL
•Sphincter controlNIL
•Pain ReliefNIL
•Improvement in motor function/Ambulatory statusNIL
Secondary Outcome Measures
NameTimeMethod
To determine whether there is any difference in outcome with respect to overall survival.NA

Trial Locations

Locations (1)

TATA MEMORIAL CENTRE, DEPARTMENT OF RADIATION ONCOLOGY

🇮🇳

Mumbai, MAHARASHTRA, India

TATA MEMORIAL CENTRE, DEPARTMENT OF RADIATION ONCOLOGY
🇮🇳Mumbai, MAHARASHTRA, India
DR JAI PRAKASH AGARWAL
Principal investigator
02224177164
agarwaljp@tmc.gov.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.